Mirjam Koker

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Journal: Cancer research
Published: December 31, 2024

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.

Journal: Nature communications
Published: November 13, 2024

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Journal: Cancer cell
Published: August 25, 2024

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.

Journal: JCI insight
Published: October 18, 2022

Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.

Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.

Journal: Pathology oncology research : POR
Published: August 19, 2020

Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.

Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.

Journal: Cell reports
Published: April 04, 2019

Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.

Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.

Journal: Oncogene
Published: November 30, 2017

HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types.

HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types.

Journal: Molecular cell
Published: September 14, 2017

LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model.

LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model.

Journal: Oncogene
Published: June 08, 2017

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.

Journal: Genome biology
Published: March 24, 2014

CD74-NRG1 fusions in lung adenocarcinoma.

CD74-NRG1 fusions in lung adenocarcinoma.

Journal: Cancer discovery
Published: January 29, 2014

A framework for identification of actionable cancer genome dependencies in small cell lung cancer.

A framework for identification of actionable cancer genome dependencies in small cell lung cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 05, 2012
Showing 1-12 of 17

Last Updated: 09/26/2026